Breaking News Instant updates and real-time market news.

CVS

CVS Health

$79.12

1.15 (1.47%)

08:38
08/08/17
08/08
08:38
08/08/17
08:38

CVS Health sees FY17 net revenue growth of 3%-4%, consensus $184.15B

Guidance from slides presentation for Q2 earnings conference call.

  • 08

    Aug

  • 21

    Sep

  • 22

    Sep

CVS CVS Health
$79.12

1.15 (1.47%)

06/27/17
LEER
06/27/17
NO CHANGE
Target $90
LEER
Outperform
CVS gained largest PBM share in 2017 selling season, says Leerink
Leerink analyst David Larsen says his firm's recently published Pharmacy Benefit Manager survey shows that CVS Health is the largest share gainer in the 2017 selling season. The company is poised to win incremental PBM and Specialty Pharmacy share, while the Optum and Cigna deals will start to benefit retail volumes in the near-term, Larsen tells investors in a research note. He keeps an Outperform rating on CVS shares with a $90 price target.
06/27/17
NEED
06/27/17
INITIATION
NEED
Hold
CVS Health initiated with a Hold at Needham
Needham analyst Kevin Caliendo initiated CVS Health with a Hold.
06/28/17
06/28/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Altaba (AABA) initiated with an Overweight at JPMorgan. 2. Aetna (AET) and Humana (HUM) were initiated with a Buy at Citi. The firm also added Aetna to its Focus List. 3. CVS Health (CVS) and Walgreens Boots Alliance (WBA) were initiated with a Hold at Needham. 4. Oaktree Capital (OAK) initiated with a Hold at Jefferies. 5. General Motors (GM) resumed with an Overweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/28/17
WELS
07/28/17
NO CHANGE
Target $9
WELS
Underperform
Insurers are dropping Valeant's top products, says Wells Fargo
United Healthcare's (UNH) formulary is no longer covering Valeant Pharmaceuticals' (VRX) number three branded drug Solodyn and will also now exclude Retin-A brand, its number four branded drug, Wells Fargo analyst David Maris tells investors in a research note. The analyst estimates the two drugs represented approximately $214M of Valeant's sales in 2016. Maris also points out that Glumetza, Valeant's number eight branded drug, and Relistor were removed in July from CVS/Caremark's (CVS) formulary. These two drugs had approximately $119M in 2016 revenues. Maris notes his counterpart Peter Costa estimates that United Healthcare covers approximately 17% of the U.S. and CVS covers approximately 33%. Express Scripts (ESRX) is releasing its 2018 national formulary next week, Costa adds. Maris keeps an Underperform rating on shares of Valeant with a $9 price target. The stock in premarket trading is down 33c, or 2%, to $16.80.

TODAY'S FREE FLY STORIES

SHLD

Sears

$1.29

-0.015 (-1.15%)

09:30
09/24/18
09/24
09:30
09/24/18
09:30
Hot Stocks
Sears announces receipt of proposal from ESL Investments »

Seas announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:30
09/24/18
09/24
09:30
09/24/18
09:30
General news
Treasury Action: Treasury yields are following Bund and other EGB rates higher »

Treasury Action: Treasury…

BSX

Boston Scientific

$37.76

-0.07 (-0.19%)

09:29
09/24/18
09/24
09:29
09/24/18
09:29
Conference/Events
Boston Scientific to hold an investor event »

In conjunction with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

VHC

VirnetX

$4.20

0.15 (3.70%)

, AAPL

Apple

$217.65

-2.35 (-1.07%)

09:27
09/24/18
09/24
09:27
09/24/18
09:27
Hot Stocks
VirnetX files notice regarding agreed bill of costs, interest in Apple suit »

VirnetX (VHC) announced…

VHC

VirnetX

$4.20

0.15 (3.70%)

AAPL

Apple

$217.65

-2.35 (-1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

TDOC

Teladoc

$78.10

2.675 (3.55%)

09:27
09/24/18
09/24
09:27
09/24/18
09:27
Recommendations
Teladoc analyst commentary  »

Teladoc price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

PG

Procter & Gamble

$85.75

0.35 (0.41%)

, AMZN

Amazon.com

$1,917.75

-26.51 (-1.36%)

09:26
09/24/18
09/24
09:26
09/24/18
09:26
Hot Stocks
Old Spice announces Beard Care Collection, available exclusively on Amazon.com »

Old Spice (PG) gets down…

PG

Procter & Gamble

$85.75

0.35 (0.41%)

AMZN

Amazon.com

$1,917.75

-26.51 (-1.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 19

    Oct

  • 03

    Mar

09:25
09/24/18
09/24
09:25
09/24/18
09:25
Conference/Events
Morgan Stanley household products analyst holds analyst/industry conference call »

Household Products,…

ANDV

Andeavor

$154.80

2.19 (1.44%)

, MPC

Marathon Petroleum

$83.37

1.44 (1.76%)

09:25
09/24/18
09/24
09:25
09/24/18
09:25
Conference/Events
Marathon Petroleum to host special shareholder meeting »

Special Shareholder…

ANDV

Andeavor

$154.80

2.19 (1.44%)

MPC

Marathon Petroleum

$83.37

1.44 (1.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 24

    Sep

BFST

Business First Bancshares

$26.96

-0.41 (-1.50%)

09:24
09/24/18
09/24
09:24
09/24/18
09:24
Initiation
Business First Bancshares initiated  »

Business First Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

UTHR

United Therapeutics

$122.86

-1.42 (-1.14%)

09:23
09/24/18
09/24
09:23
09/24/18
09:23
Conference/Events
United Therapeutics to hold a meeting »

Science Day 2018 will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

ZAGG

Zagg

$15.65

-0.15 (-0.95%)

09:21
09/24/18
09/24
09:21
09/24/18
09:21
Recommendations
Zagg analyst commentary  »

Zagg to benefit from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$162.90

-3.16 (-1.90%)

09:21
09/24/18
09/24
09:21
09/24/18
09:21
Periodicals
Facebook appoints Ajit Mohan as India managing director, The Times of India says »

Facebook has appointed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 07

    Nov

ABMD

Abiomed

$384.69

2.74 (0.72%)

09:20
09/24/18
09/24
09:20
09/24/18
09:20
Conference/Events
Abiomed to hold an investor breakfast meeting »

Annual Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 27

    Nov

BECN

Beacon Roofing

$39.38

-0.53 (-1.33%)

, OC

Owens Corning

$58.26

-0.34 (-0.58%)

09:18
09/24/18
09/24
09:18
09/24/18
09:18
Recommendations
Beacon Roofing, Owens Corning, Carlisle analyst commentary  »

Roofing estimates lowered…

BECN

Beacon Roofing

$39.38

-0.53 (-1.33%)

OC

Owens Corning

$58.26

-0.34 (-0.58%)

CSL

Carlisle

$123.80

-0.345 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 29

    Sep

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
09/24/18
09/24
09:18
09/24/18
09:18
Options
Overnight activity included 134 trades in SPX and 8 trades in VIX »

134 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QURE

uniQure

$38.40

-2.7 (-6.57%)

09:17
09/24/18
09/24
09:17
09/24/18
09:17
Recommendations
uniQure analyst commentary  »

uniQure price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 03

    Oct

FTV

Fortive

$86.97

-0.45 (-0.51%)

, AIMC

Altra Industrial Motion

$43.10

0.45 (1.06%)

09:17
09/24/18
09/24
09:17
09/24/18
09:17
Hot Stocks
Fortive sets final exchange ratio in split-off exchange offer »

Fortive Corporation (FTV)…

FTV

Fortive

$86.97

-0.45 (-0.51%)

AIMC

Altra Industrial Motion

$43.10

0.45 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QURE

uniQure

$38.40

-2.7 (-6.57%)

09:16
09/24/18
09/24
09:16
09/24/18
09:16
Hot Stocks
uniQure says third patient has been treated in AMT-061 study »

uniQure announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 03

    Oct

NVDA

Nvidia

$263.44

-2.83 (-1.06%)

09:16
09/24/18
09/24
09:16
09/24/18
09:16
Recommendations
Nvidia analyst commentary  »

Mixed reaction to Nvidia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 10

    Dec

TSLA

Tesla

$299.05

0.73 (0.24%)

09:16
09/24/18
09/24
09:16
09/24/18
09:16
Recommendations
Tesla analyst commentary  »

Tesla Model 3 production…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 29

    Oct

DNB

Dun & Bradstreet

$143.01

-0.26 (-0.18%)

09:16
09/24/18
09/24
09:16
09/24/18
09:16
Hot Stocks
Dun & Bradstreet announce expiration of 'Go Shop' period »

Dun & Bradstreet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$119.85

-0.31 (-0.26%)

09:15
09/24/18
09/24
09:15
09/24/18
09:15
Conference/Events
Neurocrine has a conference call hosted by JPMorgan »

JPMorgan Analyst Rama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

AAPL

Apple

$217.65

-2.35 (-1.07%)

, CRM

Salesforce

$155.46

-0.07 (-0.05%)

09:14
09/24/18
09/24
09:14
09/24/18
09:14
Hot Stocks
Apple, Salesforce announce strategic partnership »

Apple and Salesforce…

AAPL

Apple

$217.65

-2.35 (-1.07%)

CRM

Salesforce

$155.46

-0.07 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 03

    Mar

HAFC

Hanmi Financial

$25.65

-0.45 (-1.72%)

09:14
09/24/18
09/24
09:14
09/24/18
09:14
Conference/Events
Goldman Sachs to hold a conference »

9th Annual Regional &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 07

    Nov

CMTL

Comtech

$33.32

0.5 (1.52%)

09:11
09/24/18
09/24
09:11
09/24/18
09:11
Hot Stocks
Comtech receives $9.1M contract to supply troposcatter equipment to Iraqi Navy »

Comtech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.